Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program
Creative Medical Technology Holdings (NASDAQ: CELZ) has initiated a program to diagnose and treat patients...
